RSV antagonist | RSV inhibitor | RSV agonist

You can personalize your library with chemicals from within Selleck's inventory. Build the right library for your research endeavors by choosing from compounds in all of our available libraries.

Please contact us at [email protected] to customize your library.

You could select:

Specific Compounds Quantities 96 or 384 well Plate Map Dry/solid or DMSO solution

抗体

製品コード	製品名称	製品説明	文献中Selleckの製品使用例
S8588	ACSS2 inhibitor	ACSS2 inhibitor is the most potent and specific inhibitor of acetate-dependent acetyl-CoA synthetase 2 (ACSS2). ACSS2 inhibitor also inhibits the respiratory syncytial virus (RSV).	Cell Rep, 2023, 42(6):112583 JCI Insight, 2023, 10.1172/jci.insight.165817 Cell Rep, 2022, 39(9):110870
S0470	RSV604	RSV604 (A-60444), a novel benzodiazepine, is an inhibitor of respiratory syncytial virus (RSV) with EC50 of 0.86 μM. RSV604 has significant potential for the effective treatment of RSV disease. Phase 2.	Biomed Environ Sci, 2023, 36(2):135-145
E1398^New	Rilematovir	Rilematovir (JNJ-678, JNJ-53718678) is an antiviral agent that inhibits respiratory syncytial virus (RSV) with EC50 of 1.2 nM in HBECs. Rilematovir is also a fusion protein inhibitor.
S8588	ACSS2 inhibitor	ACSS2 inhibitor is the most potent and specific inhibitor of acetate-dependent acetyl-CoA synthetase 2 (ACSS2). ACSS2 inhibitor also inhibits the respiratory syncytial virus (RSV).	Cell Rep, 2023, 42(6):112583 JCI Insight, 2023, 10.1172/jci.insight.165817 Cell Rep, 2022, 39(9):110870
S0470	RSV604	RSV604 (A-60444), a novel benzodiazepine, is an inhibitor of respiratory syncytial virus (RSV) with EC50 of 0.86 μM. RSV604 has significant potential for the effective treatment of RSV disease. Phase 2.	Biomed Environ Sci, 2023, 36(2):135-145
E1398^New	Rilematovir	Rilematovir (JNJ-678, JNJ-53718678) is an antiviral agent that inhibits respiratory syncytial virus (RSV) with EC50 of 1.2 nM in HBECs. Rilematovir is also a fusion protein inhibitor.
E1398^New	Rilematovir	Rilematovir (JNJ-678, JNJ-53718678) is an antiviral agent that inhibits respiratory syncytial virus (RSV) with EC50 of 1.2 nM in HBECs. Rilematovir is also a fusion protein inhibitor.

RSV

RSV製品

RSV阻害剤の選択性比較